Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BIKAM Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
01
Overview
BIKAM Pharmaceuticals was an early-stage biotech company focused on developing small molecule therapeutics for ophthalmic and degenerative diseases. It was acquired by Shire in 2015 to enhance Shire's ophthalmics pipeline. Limited public information is available on its specific drug candidates or clinical progress.
- Therapeutic areas
- NeurologyOphthalmology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on BIKAM Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIKAM Pharmaceuticals.